Literature DB >> 27997434

The Crohn's and Colitis Foundation of America Survey of Inflammatory Bowel Disease Patient Health Care Access.

David T Rubin1, Lauren D Feld, Sarah R Goeppinger, Joel Margolese, Joel Rosh, Michele Rubin, Sandra Kim, Dylan M Rodriquez, Laura Wingate.   

Abstract

BACKGROUND: Despite anecdotal information about unaffordable care for patients with inflammatory bowel disease (IBD), there are no data regarding access to health care resources and expert care for patients with IBD. Our study was designed to assess IBD patients' ability to access and use care, as well as the timeliness, affordability, and financial stressors related to care.
METHODS: We modified the Centers for Disease Control National Health Interview Survey for IBD. The resultant 59-question survey was electronically mailed to the entire Crohn's and Colitis Foundation of America (CCFA) mailing list. Three thousand six hundred eight adult U.S. respondents completed the survey. Statistical analysis was performed.
RESULTS: Respondents who had insurance coverage were 96.1%, but 66.3% reported health care-related financial worry. Of the 452 patients who tried to obtain new insurance coverage in the year prior, 60.1% (n = 270) reported difficulty finding sufficient coverage. We found that 25.4% (n = 897) of patients reported delays in medical care, and 48.0% (n = 431) of those respondents reported that the delay was due to cost concerns. Respondents who were denied coverage by an insurance company were 55.3%. Risk factors for emergency department utilization included Crohn's disease, younger age, female sex, lower income, non-White race, and steroid therapy.
CONCLUSIONS: Our assessment of patient health care access suggests that many patients have health care-related financial worry and have forgone a variety of medical services because of cost, lack of prompt access to care, denial by insurance carriers, and worry over medical coverage. We also identify risk factors for emergency department utilization. These data inform additional studies and interventions to improve access for patients with IBD.

Entities:  

Mesh:

Year:  2017        PMID: 27997434     DOI: 10.1097/MIB.0000000000000994

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  8 in total

Review 1.  Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease.

Authors:  Wendy A Goodman; Ian P Erkkila; Theresa T Pizarro
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-09-08       Impact factor: 46.802

2.  Black and White Patients With Inflammatory Bowel Disease Show Similar Biologic Use Patterns With Medicaid Insurance.

Authors:  Edward L Barnes; Christina M Bauer; Robert S Sandler; Michael D Kappelman; Millie D Long
Journal:  Inflamm Bowel Dis       Date:  2021-02-16       Impact factor: 5.325

Review 3.  Autophagy and inflammation.

Authors:  Mengjia Qian; Xiaocong Fang; Xiangdong Wang
Journal:  Clin Transl Med       Date:  2017-07-26

4.  Indicators of suboptimal biologic therapy over time in patients with ulcerative colitis and Crohn's disease in the United States.

Authors:  Haridarshan Patel; Trevor Lissoos; David T Rubin
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

5.  The Telemedicine for Patients With Inflammatory Bowel Disease (TELE-IBD) Clinical Trial: Qualitative Assessment of Participants' Perceptions.

Authors:  Charlene Connolly Quinn; Sarah Chard; Katharine M Russman; Raymond K Cross; Erin G Roth; J Kevin Eckert
Journal:  J Med Internet Res       Date:  2019-06-03       Impact factor: 5.428

6.  Economic Burden and Health Care Access for Patients With Inflammatory Bowel Diseases in China: Web-Based Survey Study.

Authors:  Qiao Yu; Chunpeng Zhu; Shuyi Feng; Liyi Xu; Shurong Hu; Hao Chen; Hanwen Chen; Sheng Yao; Xiaoying Wang; Yan Chen
Journal:  J Med Internet Res       Date:  2021-01-05       Impact factor: 5.428

7.  Autophagy Activation Protects Ocular Surface from Inflammation in a Dry Eye Model In Vitro.

Authors:  Zhao Liu; Ding Chen; Xin Chen; Fang Bian; Ning Gao; Jinmiao Li; Stephen C Pflugfelder; De-Quan Li
Journal:  Int J Mol Sci       Date:  2020-11-26       Impact factor: 5.923

8.  National Estimates of Financial Hardship From Medical Bills and Cost-related Medication Nonadherence in Patients With Inflammatory Bowel Diseases in the United States.

Authors:  Nghia H Nguyen; Rohan Khera; Parambir S Dulai; Brigid S Boland; Lucila Ohno-Machado; William J Sandborn; Siddharth Singh
Journal:  Inflamm Bowel Dis       Date:  2021-06-15       Impact factor: 7.290

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.